The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mann William Roland since 2021.
This trader's CIK number is 1819276.
At the time of last reporting, Mann William Roland was the Chief Operating Officer of Neubase Therapeutics, Inc.. (stock ticker symbol NBSE).
Also see all insider trading activities at Neubase Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NBSE | 6,200 | $11,904 | 0 | $0 | 0 | $0 |
| 2021 | NBSE | 5,000 | $25,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-30 | NBSE | Buy | 6,200 | 1.92 | 11,904 |
| 2021-04-26 | NBSE | Buy | 5,000 | 5.00 | 25,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mann William Roland (Chief Operating Officer of Neubase Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.